Pulmonx Q3 rev $21.5M (+5%), net loss $14.0M; guides FY rev $89-90M; adds COO role

Pulmonx Corp

2025-Q3 EPS reported -$1.08 revenue$67,899,000

Worldwide revenue $21.5M (+5% YoY); US $14.0M (+1%), Intl $7.5M (+15%).
Gross margin 75% vs 74% YoY; net loss $14.0M ($0.34/share) vs $14.1M ($0.36) YoY.
Adjusted EBITDA loss $8.2M vs $8.1M YoY; cash $76.5M.
FY2025 revenue guidance narrowed to $89-90M; operating expenses $125-126M incl ~$21M SBC.
Glen French reappointed CEO; Derrick Sung appointed COO & CFO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.